Currently, there are 234.00M common shares owned by the public and among those 207.32M shares have been available to trade.
The company’s stock has a 5-day price change of 0.15% and 17.86% over the past three months. BKD shares are trading 31.21% year to date (YTD), with the 12-month market performance down to -0.75% lower. It has a 12-month low price of $4.45 and touched a high of $8.12 over the same period. BKD has an average intraday trading volume of 3.13 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.78%, 4.33%, and 11.26% respectively.
Institutional ownership of Brookdale Senior Living Inc (NYSE: BKD) shares accounts for 90.06% of the company’s 234.00M shares outstanding.
It has a market capitalization of $1.55B and a beta (3y monthly) value of 0.83. The earnings-per-share (ttm) stands at -$1.04. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.38% over the week and 1.85% over the month.
Analysts forecast that Brookdale Senior Living Inc (BKD) will achieve an EPS of -0.15 for the current quarter, -0.17 for the next quarter and -0.45 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.16 while analysts give the company a high EPS estimate of -0.16. Comparatively, EPS for the current quarter was -0.23 a year ago. Earnings per share for the fiscal year are expected to increase by 17.13%, and 33.90% over the next financial year.
Looking at the support for the BKD, a number of firms have released research notes about the stock. Barclays stated their Equal Weight rating for the stock in a research note on April 01, 2025, with the firm’s price target at $7. Jefferies coverage for the Brookdale Senior Living Inc (BKD) stock in a research note released on October 16, 2024 offered a Buy rating with a price target of $8. BofA Securities was of a view on October 07, 2024 that the stock is Underperform, while Macquarie gave the stock Outperform rating on June 28, 2024, issuing a price target of $7.50. BofA Securities on their part issued Neutral rating on December 15, 2023.
